| Literature DB >> 22214497 |
Emil Schüler1, Toshima Z Parris, Nils Rudqvist, Khalil Helou, Eva Forssell-Aronsson.
Abstract
BACKGROUND: The aim of this study was to investigate the global gene expression response of normal tissues following internal low absorbed dose irradiation of 131I.Entities:
Year: 2011 PMID: 22214497 PMCID: PMC3251037 DOI: 10.1186/2191-219X-1-29
Source DB: PubMed Journal: EJNMMI Res Impact factor: 3.138
Dosimetric estimation
| Kidneys | Liver | Lungs | Spleen | Reference | |
|---|---|---|---|---|---|
| Cumulated activity ( | 161544 | 313027 | 217091 | 49087 | Lundh et al. [ |
| Energy per decay ( | 190 | 190 | 190 | 190 | MIRD [ |
| Absorbed fraction ( | 0.919 | 0.954 | 0.85 | 0.854 | Flynn et al. [ |
| Mass (g) | 0.34 | 1.2 | 0.15 | 0.079 | |
| 0.17 | 0.10 | 0.49 | 0.21 | ||
| 1.7 | 0.98 | 4.9 | 2.1 | ||
| 3.5 | 2.0 | 9.7 | 4.2 |
Values used for the absorbed dose calculation, Ã, ni × Ei , and ϕi, are given with references, together with the mass of the organs. The estimated absorbed doses, D, delivered to the different tissues from 13, 130, and 260 kBq 131I are shown.
Total number of regulated transcripts in 131I irradiated tissues
| Number of transcripts regulated per injected activity | |||||||
|---|---|---|---|---|---|---|---|
| Total number of transcripts regulated | 13 kBq 131I | 130 kBq 131I | 260 kBq 131I | ||||
| Kidney medulla | 423 | 160 | ↑50 (31%) | 158 | ↑65 (41%) | 208 | ↑65 (31%) |
| ↓110 (69%) | ↓93 (59%) | ↓143 (69%) | |||||
| Kidney cortex | 260 | 154 | ↑87 (56%) | 85 | ↑30 (35%) | 93 | ↑60 (65%) |
| ↓67 (44%) | ↓55 (65%) | ↓33 (35%) | |||||
| Liver | 738 | 417 | ↑250 (60%) | 427 | ↑264 (62%) | 455 | ↑292 (64%) |
| ↓167(40%) | ↓163(38%) | ↓163(36%) | |||||
| Lung | 857 | 320 | ↑149(47%) | 113 | ↑82(73%) | 596 | ↑475(80%) |
| ↓171(53%) | ↓31(27%) | ↓121(20%) | |||||
| Spleen | 607 | 240 | ↑158(66%) | 306 | ↑240(78%) | 238 | ↑176(74%) |
| ↓82(34%) | ↓66(22%) | ↓62(26%) | |||||
Data on changes in gene expression after i.v. injection of 13, 130, or 260 kBq. The total number of transcripts regulated in the tissues investigated is given together with the number of up- (arrows pointing up) and downregulated (arrows pointing down) transcripts given as the total number and percentage (in parentheses).
Figure 1Regulated transcripts and modulated biological processes. Venn-diagram presenting the distribution of (A) the regulated transcripts and (B) the modulated biological processes between the different groups. Data for kidney cortex, kidney medulla, liver, lung, and spleen are shown. In general, more regulated transcripts and affected biological processes were specific for the different groups. In contrast, a more shared pattern of gene regulation for all three 131I activity levels was observed in the liver.
Strongest modulated transcripts.
| Liver | Spleen | Lung | Kidney cortex | Kidney medulla | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Up | Down | Up | Down | Up | Down | Up | Down | Up | Down | |
| 13 kBq 131I | - | - | ||||||||
| 130 kBq 131I | - | - | - | |||||||
| 260 kBq 131I | - | - | ||||||||
Ten most strongly up- and down-regulated transcripts in the different tissues investigated. Numbers in parenthesis indicate the fold change.
Transcripts in common between two or more tissues
| Liver | Spleen | Lung | Cortex | Medulla | Number | Genes in common | Comment |
|---|---|---|---|---|---|---|---|
| ↑ | ↑ | 16 | Response to stimulus; metabolism, transport | ||||
| ↓ | ↑ | 1 | Cell death | ||||
| ↑ | ↓ | 5 | Response to stimulus; immune response | ||||
| ↓ | ↑ | 1 | |||||
| ↑ | ↓ | 4 | Response to stimulus; immune response | ||||
| ↑ | ↑ | 9 | Response to stimulus; transport | ||||
| ↑ | ↑ | 3 | Response to stimulus; immune response | ||||
| ↓ | ↓ | 7 | Immune response; developmental process; metabolism | ||||
| ↓ | ↑ | 5 | Immune response; metabolism | ||||
| ↓ | ↓ | 1 | |||||
| ↓ | ↑ | 2 | |||||
| ↑ | ↓ | 6 | Immune response; metabolism; transport | ||||
| ↑ | ↑ | 11 | Response to stimulus; transport | ||||
| ↓ | ↓ | 7 | Response to stimulus | ||||
| ↓ | ↑ | 2 | Immune response | ||||
| ↑ | ↑ | 23 | Response to stimulus; cellular process; transport | ||||
| ↓ | ↓ | 4 | Immune response; metabolism | ||||
| ↓ | ↑ | 1 | |||||
| ↑ | ↓ | 1 | Cell cycle regulation | ||||
| ↑ | ↑ | 3 | Cell cycle regulation | ||||
| ↓ | ↓ | 7 | Response to stimulus; immune response; metabolism | ||||
| ↑ | ↓ | 6 | Cell cycle regulation; transport | ||||
| ↑ | ↑ | 2 | Cell cycle regulation | ||||
| ↓ | ↓ | 4 | Immune response | ||||
| ↑ | ↓ | 3 | Immune response; metabolism | ||||
| ↑ | ↑ | 6 | Response to stimulus; metabolism | ||||
| ↓ | ↓ | 10 | Response to stimulus; immune response; cell cycle regulation | ||||
| ↑ | ↓ | 2 | Immune response; metabolism | ||||
| ↑ | ↑ | 6 | Response to stimulus | ||||
| ↓ | ↓ | 13 | Immune response; metabolism | ||||
| ↓ | ↑ | 1 | |||||
| ↑ | ↓ | 1 | |||||
| ↑ | ↑ | 7 | Response to stimulus; metabolism | ||||
| ↑ | ↓ | ↓ | 1 | Response to stimulus | |||
| ↑ | ↑ | ↑ | 7 | Response to stimulus; transport | |||
| ↑ | ↑ | ↓ | 1 | Transport | |||
| ↑ | ↑ | ↑ | 1 | ||||
| ↓ | ↑ | ↓ | 1 | ||||
| ↑ | ↑ | ↑ | 1 | Response to stimulus | |||
| ↓ | ↑ | ↑ | 1 | ||||
| ↑ | ↓ | ↓ | 1 | Immune response | |||
| ↑ | ↑ | ↑ | 2 | Response to stimulus | |||
| ↓ | ↓ | ↑ | 1 | ||||
| ↑ | ↓ | ↓ | 3 | Immune response; metabolism | |||
| ↑ | ↑ | ↑ | 1 | Response to stimulus | |||
| ↓ | ↓ | ↓ | 1 | ||||
| ↓ | ↑ | ↓ | 1 | Immune response | |||
| ↑ | ↑ | ↑ | 2 | ||||
| ↓ | ↓ | ↓ | 3 | Response to stimulus | |||
| ↑ | ↑ | ↑ | 2 | ||||
| ↓ | ↓ | ↓ | 2 | Immune response | |||
| ↑ | ↑ | ↓ | 1 | ||||
| ↑ | ↑ | ↑ | 1 | ||||
| ↓ | ↓ | ↓ | 4 | Immune response | |||
| ↑ | ↓ | ↓ | 2 | Immune response | |||
| ↑ | ↓ | ↑ | 1 | ||||
| ↑ | ↑ | ↑ | 3 | Response to stimulus | |||
| ↓ | ↑ | ↓ | ↑ | 1 | |||
| ↑ | ↑ | ↑ | ↑ | 1 | Response to stimulus | ||
| ↑ | ↑ | ↑ | ↑ | 1 | |||
| ↓ | ↓ | ↓ | ↓ | 1 | |||
| ↓ | ↑ | ↓ | ↓ | 1 | Immune response | ||
| ↑ | ↑ | ↑ | ↑ | 1 |
Comparison was conducted with the aim of keeping the absorbed dose to the different tissues constant. The absorbed doses for the different tissues were 1.7, 2.0, 4.9, and 2.1 mGy for the kidney, liver, lung, and spleen, respectively. Arrows that are pointing up denote upregulation, while arrows that are pointing down denote downregulation.
Figure 2Dose-response relationship for the transcripts found to be regulated at all absorbed dose levels.
Common biological processes
| Tissue combination | Biological process |
|---|---|
| Kidney cortex-kidney medulla | Amiloride transport |
| Amino acid transport | |
| Bone remodeling | |
| Canalicular bile acid transport | |
| Choline metabolism | |
| Negative regulation of cell adhesion | |
| Negative regulation of enzyme activity | |
| Positive regulation of actin filament polymerization | |
| Protection from natural killer cell mediated cytotoxicity | |
| Regulation of hormone secretion | |
| Transport | |
| Kidney cortex-liver | Acetyl-CoA metabolism |
| Cytolysis | |
| Response to sterol depletion | |
| Retinoid metabolism | |
| Steroid biosynthesis | |
| Thermoregulation | |
| Kidney cortex-lung | Cellular response to starvation |
| Cytoskeleton organization and biogenesis | |
| Fatty acid oxidation | |
| Patterning of blood vessels | |
| Positive regulation of glucose import | |
| Positive regulation of lipid metabolism | |
| Protein folding | |
| Regulation of transcription from RNA polymerase II promoter | |
| Kidney cortex-spleen | Regulation of axon extension |
| Regulation of neuronal synaptic plasticity | |
| Response to oxidative stress | |
| Ubiquitin-dependent protein catabolism | |
| Kidney medulla-liver | Digestion |
| Kidney medulla-lung | Cell migration |
| Cell-matrix adhesion | |
| Cellular defense response | |
| Positive regulation of angiogenesis | |
| Positive regulation of neurotransmitter secretion | |
| Regulation of locomotion | |
| Regulation of long-term neuronal synaptic plasticity | |
| Response to hypoxia | |
| Synaptic vesicle transport | |
| Kidney medulla-spleen | Cartilage condensation |
| Central nervous system development | |
| Complement activation; alternative pathway | |
| Neuropeptide signaling pathway | |
| Positive regulation of small GTPase mediated signal transduction | |
| Response to nutrient | |
| Liver-lung | Embryonic heart tube development |
| Fatty acid metabolism | |
| Metabolism | |
| Liver-spleen | Negative regulation of signal transduction |
| Regulation of cell growth | |
| Lung-spleen | Iron ion homeostasis |
| Peptidoglycan metabolism | |
| Response to biotic stimulus | |
| Kidney cortex-kidney medulla-lung | Negative regulation of apoptosis |
| Kidney cortex-kidney medulla-spleen | Defense response |
| Kidney cortex-liver-lung | Acute-phase response |
| Complement activation | |
| Lipid metabolism | |
| Kidney cortex-lung-spleen | Response to glucose stimulus |
| Kidney medulla-lung-spleen | Positive regulation of non-apoptotic programmed cell death |
| Liver-lung-spleen | Response to heat |
| Response to unfolded protein | |
| Kidney cortex-kidney medulla-liver-lung | Electron transport |
| Kidney cortex-kidney medulla-lung-spleen | Inflammatory response |
| Negative regulation of gluconeogenesis | |
| Negative regulation of lipoprotein lipase activity | |
| Positive regulation of fatty acid metabolism | |
| Positive regulation of signal transduction | |
| Kidney cortex-kidney medulla-liver-lung-spleen | Immune response |
Biological processes affected in two or more tissues independent of the absorbed dose. All processes had a p value < 0.05. Additional information is presented in Additional file 1.
Parental biological processes
| Kidney cortex | Kidney medulla | Liver | Lung | Spleen | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13 kBq | 130 kBq | 260 kBq | 13 kBq | 130 kBq | 260 kBq | 13 kBq | 130 kBq | 260 kBq | 13 kBq | 130 kBq | 260 kBq | 13 kBq | 130 kBq | 260 kBq | |
| Metabolism | 27% (3) | 38% (9) | 34% (5) | 11% (1) | 8% (1) | 59% (13) | 85% (11) | 54% (14) | 9% (3) | 27% (8) | 57% (21) | 46% (6) | 30% (7) | 30% (7) | |
| Transport | 27% (3) | 4% (1) | 11% (1) | 18% (2) | 17% (5) | 11% (4) | 15% (2) | 4% (1) | |||||||
| Cellular process | 9% (1) | 13% (3) | 13% (2) | 33% (3) | 9% (1) | 42% (5) | 5% (1) | 8% (1) | 4% (1) | 38% (12) | 10% (3) | 5% (2) | 44% (10) | 13% (3) | |
| System process | 4% (1) | 7% (1) | 8% (1) | 9% (2) | 17% (5) | 16% (6) | |||||||||
| Developmental process | 18% (2) | 8% (2) | 13% (2) | 22% (2) | 27% (3) | 25% (3) | 9% (2) | 8% (1) | 12% (3) | 3% (1) | 10% (3) | 8% (3) | 4% (1) | ||
| Immune response | 13% (3) | 13% (2) | 18% (2) | 9% (2) | 12% (3) | 22% (7) | 15% (2) | 17% (4) | 9% (2) | ||||||
| Response to stimulus and stress | 18% (2) | 21% (5) | 20% (3) | 22% (2) | 27% (3) | 17% (2) | 9% (2) | 19% (5) | 28% (9) | 20% (6) | 3% (1) | 23% (3) | 9% (2) | 39% (9) | |
The fraction of affected biological processes in the investigated tissues, grouped into parental biological processes. The numbers are calculated as the fraction of affected processes per parental process and per injected activity divided by the total number of processes affected per injected activity and tissue. The number of biological processes is given in parenthesis.